ASENAPINE

ASENAPINE was reported 8671 times

These side effects are most commonly reported by patients taking ASENAPINE:

# Side effect Count
0 DRUG INEFFECTIVE 115
1 DRUG INTERACTION 87
2 OFF LABEL USE 74
3 COMPLETED SUICIDE 73
4 TOXICITY TO VARIOUS AGENTS 67
5 MYOCARDITIS 58
6 SEDATION 40
7 DEPRESSION 36
8 SOMNOLENCE 32
9 SUICIDAL IDEATION 32
10 PRODUCT SUBSTITUTION ISSUE 31
11 WEIGHT INCREASED 31
12 ANXIETY 29
13 HYPOTENSION 28
14 INSOMNIA 28
15 CONDITION AGGRAVATED 27
16 DYSTONIA 26
17 SEROTONIN SYNDROME 26
18 HALLUCINATION, AUDITORY 24
19 MANIA 24
20 TREATMENT FAILURE 24
21 AKATHISIA 23
22 PRODUCT SOLUBILITY ABNORMAL 23
23 PRODUCT USE IN UNAPPROVED INDICATION 23
24 VOMITING 23
25 COVID-19 22
26 ELECTROCARDIOGRAM QT PROLONGED 22
27 EXTRAPYRAMIDAL DISORDER 22
28 ACUTE KIDNEY INJURY 21
29 CONSTIPATION 20
30 DECREASED APPETITE 20
31 SINUS TACHYCARDIA 20
32 WEIGHT DECREASED 20
33 DEPRESSED MOOD 19
34 NAUSEA 19
35 CARDIAC ARREST 18
36 DIZZINESS 18
37 NEUROLEPTIC MALIGNANT SYNDROME 18
38 TREMOR 18
39 AGITATION 17
40 DEATH 17
41 DELUSION 17
42 PSYCHOTIC DISORDER 17
43 SCHIZOPHRENIA 17
44 DISEASE RECURRENCE 16
45 NEUTROPENIA 16
46 PARKINSONISM 16
47 RHABDOMYOLYSIS 16
48 SUICIDE ATTEMPT 16
49 DYSKINESIA 15
50 FALL 15
51 SEIZURE 15
52 TACHYCARDIA 15
53 CARDIO-RESPIRATORY ARREST 14
54 CONFUSIONAL STATE 14
55 DRUG ABUSE 14
56 DRUG RESISTANCE 14
57 FEELING ABNORMAL 14
58 MENTAL IMPAIRMENT 14
59 OEDEMA 14
60 PARANOIA 14
61 RESTLESSNESS 14
62 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 14
63 TREATMENT NONCOMPLIANCE 14
64 CATAPLEXY 13
65 CELLULITIS 13
66 CEREBRAL ATROPHY 13
67 DYSPNOEA 13
68 OVERDOSE 13
69 SWELLING FACE 13
70 AGGRESSION 12
71 CONJUNCTIVITIS 12
72 DEAFNESS 12
73 DEMENTIA ALZHEIMER^S TYPE 12
74 EYELID OEDEMA 12
75 HALLUCINATION, VISUAL 12
76 HEADACHE 12
77 LABELLED DRUG-DRUG INTERACTION ISSUE 12
78 LIVER FUNCTION TEST ABNORMAL 12
79 MALAISE 12
80 NO ADVERSE EVENT 12
81 SYNCOPE 12
82 THERMAL BURNS OF EYE 12
83 TINNITUS 12
84 VASCULAR DEMENTIA 12
85 ABNORMAL BEHAVIOUR 11
86 DIARRHOEA 11
87 HALLUCINATION 11
88 HYPONATRAEMIA 11
89 IRRITABILITY 11
90 SALIVARY HYPERSECRETION 11
91 SELECTIVE EATING DISORDER 11
92 APPLICATION SITE IRRITATION 10
93 CHOLELITHIASIS 10
94 CONGESTIVE CARDIOMYOPATHY 10
95 DELIRIUM 10
96 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 10
97 OCULOGYRIC CRISIS 10
98 SEXUAL DYSFUNCTION 10
99 SPEECH DISORDER 10
100 TRICUSPID VALVE INCOMPETENCE 10
101 DEPRESSED LEVEL OF CONSCIOUSNESS 9
102 FATIGUE 9
103 GAIT DISTURBANCE 9
104 LEUKOPENIA 9
105 PULMONARY VALVE INCOMPETENCE 9
106 PYREXIA 9
107 RASH 9
108 TARDIVE DYSKINESIA 9
109 THINKING ABNORMAL 9
110 APPLICATION SITE ERYTHEMA 8
111 ASPIRATION 8
112 BLOOD GLUCOSE INCREASED 8
113 DRUG DOSE OMISSION 8
114 EMBOLIC STROKE 8
115 HYPERTENSION 8
116 INCORRECT DOSE ADMINISTERED 8
117 INTENTIONAL OVERDOSE 8
118 INTENTIONAL PRODUCT MISUSE 8
119 IRON DEFICIENCY ANAEMIA 8
120 LEFT VENTRICULAR DYSFUNCTION 8
121 MITRAL VALVE INCOMPETENCE 8
122 MUSCLE SPASMS 8
123 MUSCULAR WEAKNESS 8
124 RESPIRATION ABNORMAL 8
125 SOCIAL ANXIETY DISORDER 8
126 URINARY TRACT INFECTION 8
127 WHITE BLOOD CELL COUNT DECREASED 8
128 ACCIDENTAL OVERDOSE 7
129 COUGH 7
130 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7
131 DRUG WITHDRAWAL SYNDROME 7
132 DYSPHAGIA 7
133 HYPERSENSITIVITY 7
134 HYPERSOMNIA 7
135 HYPOAESTHESIA 7
136 HYPOAESTHESIA ORAL 7
137 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 7
138 LEUKOCYTOSIS 7
139 LOSS OF CONSCIOUSNESS 7
140 METABOLIC ACIDOSIS 7
141 MICROCYTIC ANAEMIA 7
142 MUSCLE RIGIDITY 7
143 OEDEMA PERIPHERAL 7
144 POLYDIPSIA 7
145 PULMONARY OEDEMA 7
146 RESPIRATORY ARREST 7
147 RHINORRHOEA 7
148 SEDATION COMPLICATION 7
149 UNDERDOSE 7
150 ABDOMINAL DISCOMFORT 6
151 CEREBROVASCULAR ACCIDENT 6
152 COGWHEEL RIGIDITY 6
153 DEHYDRATION 6
154 DIABETES MELLITUS 6
155 DISORIENTATION 6
156 DRUG HYPERSENSITIVITY 6
157 DRY MOUTH 6
158 GLOSSODYNIA 6
159 MAJOR DEPRESSION 6
160 MEIGE^S SYNDROME 6
161 MYASTHENIC SYNDROME 6
162 NEGATIVE THOUGHTS 6
163 NEPHROGENIC DIABETES INSIPIDUS 6
164 NEUTROPHIL COUNT DECREASED 6
165 PAIN 6
166 PLEUROTHOTONUS 6
167 POLLAKIURIA 6
168 PRODUCT INEFFECTIVE 6
169 PRODUCT RESIDUE PRESENT 6
170 PRODUCT TASTE ABNORMAL 6
171 PSYCHOTIC SYMPTOM 6
172 PULMONARY CONGESTION 6
173 SOPOR 6
174 STOMATITIS 6
175 THERAPEUTIC PRODUCT INEFFECTIVE 6
176 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6
177 ABDOMINAL PAIN 5
178 ADVERSE EVENT 5
179 ANTICHOLINERGIC SYNDROME 5
180 APHASIA 5
181 ASPHYXIA 5
182 ATRIAL FLUTTER 5
183 BRADYCARDIA 5
184 BUNDLE BRANCH BLOCK LEFT 5
185 BUNDLE BRANCH BLOCK RIGHT 5
186 CARDIOMYOPATHY 5
187 CATATONIA 5
188 CHEST DISCOMFORT 5
189 CHEST PAIN 5
190 DEEP VEIN THROMBOSIS 5
191 DYSARTHRIA 5
192 EYE MOVEMENT DISORDER 5
193 HEAD TITUBATION 5
194 HEPATOTOXICITY 5
195 HYPERNATRAEMIA 5
196 HYPERTHYROIDISM 5
197 HYPOGLYCAEMIA 5
198 INTENTIONAL SELF-INJURY 5
199 JOINT SWELLING 5
200 MEMORY IMPAIRMENT 5
201 MENTAL STATUS CHANGES 5
202 MOOD ALTERED 5
203 MUSCLE TWITCHING 5
204 MYOCARDIAL INFARCTION 5
205 MYOCARDIAL ISCHAEMIA 5
206 NERVOUSNESS 5
207 ORAL DISCOMFORT 5
208 ORTHOSTATIC HYPOTENSION 5
209 PAIN IN EXTREMITY 5
210 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 5
211 PRODUCT PHYSICAL ISSUE 5
212 PRODUCT QUALITY ISSUE 5
213 PULMONARY EMBOLISM 5
214 RESPIRATORY FAILURE 5
215 SELF-INJURIOUS IDEATION 5
216 SLEEP DISORDER 5
217 SUBSTANCE ABUSE 5
218 SWOLLEN TONGUE 5
219 THYROIDITIS ACUTE 5
220 TOURETTE^S DISORDER 5
221 UNRESPONSIVE TO STIMULI 5
222 WEIGHT ABNORMAL 5
223 WHITE BLOOD CELL COUNT INCREASED 5
224 ABDOMINAL PAIN UPPER 4
225 ACUTE PSYCHOSIS 4
226 ALOPECIA 4
227 ALTERED STATE OF CONSCIOUSNESS 4
228 ANGER 4
229 APPLICATION SITE RASH 4
230 ARTHRALGIA 4
231 ASTHENIA 4
232 AUTONOMIC NERVOUS SYSTEM IMBALANCE 4
233 BALANCE DISORDER 4
234 BIPOLAR I DISORDER 4
235 BLOOD CREATINE PHOSPHOKINASE INCREASED 4
236 BLOOD SODIUM DECREASED 4
237 BRADYKINESIA 4
238 BURNING SENSATION 4
239 CARDIOMETABOLIC SYNDROME 4
240 COGNITIVE DISORDER 4
241 DOPAMINE SUPERSENSITIVITY PSYCHOSIS 4
242 DRUG EFFECT INCOMPLETE 4
243 DRUG-INDUCED LIVER INJURY 4
244 DYSGEUSIA 4
245 DYSPHONIA 4
246 DYSSTASIA 4
247 ELECTROCARDIOGRAM T WAVE ABNORMAL 4
248 EUPHORIC MOOD 4
249 GALACTORRHOEA 4
250 GLYCOSYLATED HAEMOGLOBIN INCREASED 4
251 HYPERGLYCAEMIA 4
252 HYPOACUSIS 4
253 HYPOXIA 4
254 IMPAIRED QUALITY OF LIFE 4
255 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4
256 INCREASED APPETITE 4
257 LACTIC ACIDOSIS 4
258 MANIC SYMPTOM 4
259 MENTAL DISORDER 4
260 OBSESSIVE-COMPULSIVE DISORDER 4
261 PANCREATIC STEATOSIS 4
262 PARAESTHESIA 4
263 PNEUMONIA 4
264 POOR QUALITY SLEEP 4
265 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 4
266 PRODUCT ADMINISTRATION ERROR 4
267 PRODUCT DOSE OMISSION ISSUE 4
268 PRODUCT USE COMPLAINT 4
269 PRODUCT USE ISSUE 4
270 PROSTATOMEGALY 4
271 PRURITUS 4
272 QRS AXIS ABNORMAL 4
273 RENAL IMPAIRMENT 4
274 RESPIRATORY DISTRESS 4
275 SUSPECTED SUICIDE 4
276 THERAPEUTIC PRODUCT EFFECT DECREASED 4
277 THERAPY NON-RESPONDER 4
278 TONGUE DISCOMFORT 4
279 TUBULOINTERSTITIAL NEPHRITIS 4
280 TYPE 2 DIABETES MELLITUS 4
281 ADVERSE DRUG REACTION 3
282 AGRANULOCYTOSIS 3
283 ALANINE AMINOTRANSFERASE INCREASED 3
284 AMENORRHOEA 3
285 ANAEMIA 3
286 ANHEDONIA 3
287 ANOSOGNOSIA 3
288 APPLICATION SITE PRURITUS 3
289 ARRHYTHMIA 3
290 ASPARTATE AMINOTRANSFERASE INCREASED 3
291 ASTHMA 3
292 BLOOD PRESSURE INCREASED 3
293 BLOOD PROLACTIN INCREASED 3
294 C-REACTIVE PROTEIN INCREASED 3
295 CHOKING SENSATION 3
296 CONVULSION 3
297 DEVICE ADHESION ISSUE 3
298 DEVICE DIFFICULT TO USE 3
299 DISTURBANCE IN SOCIAL BEHAVIOUR 3
300 DRUG INTOLERANCE 3
301 DRUG LEVEL INCREASED 3
302 DYSLIPIDAEMIA 3
303 DYSMETRIA 3
304 DYSPEPSIA 3
305 ELECTROCARDIOGRAM T WAVE INVERSION 3
306 EMBOLISM VENOUS 3
307 ENURESIS 3
308 EXCESSIVE EYE BLINKING 3
309 EXPOSURE DURING PREGNANCY 3
310 FEELINGS OF WORTHLESSNESS 3
311 FOETAL EXPOSURE DURING PREGNANCY 3
312 GAIT INABILITY 3
313 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3
314 HAEMOGLOBIN DECREASED 3
315 HEPATIC ENZYME INCREASED 3
316 HOSPITALISATION 3
317 HYPERKALAEMIA 3
318 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3
319 LOGORRHOEA 3
320 LOWER RESPIRATORY TRACT INFECTION 3
321 MEDICATION ERROR 3
322 METABOLIC DISORDER 3
323 METABOLIC SYNDROME 3
324 MICROCYTOSIS 3
325 MOUTH ULCERATION 3
326 MOVEMENT DISORDER 3
327 MYALGIA 3
328 NIGHTMARE 3
329 ORAL MUCOSAL BLISTERING 3
330 PANIC REACTION 3
331 PARKINSON^S DISEASE 3
332 PERICARDIAL EFFUSION 3
333 POLYHYDRAMNIOS 3
334 POST-TRAUMATIC STRESS DISORDER 3
335 PREMATURE DELIVERY 3
336 PRIAPISM 3
337 PRODUCT FORMULATION ISSUE 3
338 PRODUCT PRESCRIBING ERROR 3
339 PSYCHIATRIC DECOMPENSATION 3
340 PSYCHOMOTOR HYPERACTIVITY 3
341 PSYCHOMOTOR RETARDATION 3
342 SELF-MEDICATION 3
343 SENSORY DISTURBANCE 3
344 SHOCK 3
345 TONGUE OEDEMA 3
346 URINARY RETENTION 3
347 VENTRICULAR HYPOKINESIA 3
348 VISCERAL CONGESTION 3
349 VISION BLURRED 3
350 VISUAL IMPAIRMENT 3
351 ABDOMINAL DISTENSION 2
352 ABULIA 2
353 AFFECTIVE DISORDER 2
354 AMNESIA 2
355 ANGIOEDEMA 2
356 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 2
357 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 2
358 ANTIPSYCHOTIC DRUG LEVEL INCREASED 2
359 AORTIC VALVE INCOMPETENCE 2
360 APATHY 2
361 APPLICATION SITE PAIN 2
362 APRAXIA 2
363 BACK PAIN 2
364 BIPOLAR DISORDER 2
365 BLISTER 2
366 BLOOD CREATINE INCREASED 2
367 BLOOD CREATININE INCREASED 2
368 BLOOD IRON DECREASED 2
369 BLOOD LACTIC ACID INCREASED 2
370 BLOOD PRESSURE DECREASED 2
371 BLOOD PROLACTIN ABNORMAL 2
372 BRADYPNOEA 2
373 BURN ORAL CAVITY 2
374 CARDIAC DISORDER 2
375 CARDIOVASCULAR DISORDER 2
376 CHOLECYSTECTOMY 2
377 CHRONIC KIDNEY DISEASE 2
378 CLONUS 2
379 COMA 2
380 CONVERSION DISORDER 2
381 CORONARY ARTERY DISEASE 2
382 CREPITATIONS 2
383 CYANOSIS 2
384 DEVICE ISSUE 2
385 DISEASE PROGRESSION 2
386 DISINHIBITION 2
387 DISSOCIATION 2
388 DISSOCIATIVE IDENTITY DISORDER 2
389 DISTURBANCE IN ATTENTION 2
390 DROOLING 2
391 DRUG ADMINISTRATION ERROR 2
392 DRUG DISPENSED TO WRONG PATIENT 2
393 DYSDIADOCHOKINESIS 2
394 DYSGRAPHIA 2
395 ELECTROCARDIOGRAM ABNORMAL 2
396 EMOTIONAL DISORDER 2
397 END STAGE RENAL DISEASE 2
398 EXERCISE TOLERANCE DECREASED 2
399 EXPOSURE VIA INGESTION 2
400 EYE PAIN 2
401 FACIAL PARESIS 2
402 FACIAL SPASM 2
403 FEAR 2
404 FEBRILE NEUTROPENIA 2
405 FEEDING DISORDER 2
406 FORMICATION 2
407 GASTROINTESTINAL HYPOMOTILITY 2
408 GENERAL PHYSICAL HEALTH DETERIORATION 2
409 GLOSSITIS 2
410 GYNAECOMASTIA 2
411 HAEMORRHAGE 2
412 HOT FLUSH 2
413 HYPERCHOLESTEROLAEMIA 2
414 HYPERHIDROSIS 2
415 HYPERPROLACTINAEMIA 2
416 HYPERTHERMIA 2
417 HYPERTRIGLYCERIDAEMIA 2
418 HYPERVENTILATION 2
419 HYPOMANIA 2
420 HYPOPHAGIA 2
421 HYPOTHERMIA 2
422 IMMUNOGLOBULINS DECREASED 2
423 IMPAIRED DRIVING ABILITY 2
424 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2
425 INITIAL INSOMNIA 2
426 INSURANCE ISSUE 2
427 INTESTINAL OBSTRUCTION 2
428 ISCHAEMIA 2
429 LETHARGY 2
430 LEUKAEMIA 2
431 LIVER DISORDER 2
432 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2
433 MATERNAL EXPOSURE DURING PREGNANCY 2
434 MIDDLE INSOMNIA 2
435 MIGRAINE 2
436 MOOD SWINGS 2
437 MUSCLE TIGHTNESS 2
438 MUSCULOSKELETAL STIFFNESS 2
439 MYOSITIS 2
440 NECK PAIN 2
441 NEPHROLITHIASIS 2
442 NEUTROPHIL COUNT INCREASED 2
443 NYSTAGMUS 2
444 OBESITY 2
445 ORAL DISORDER 2
446 ORAL MUCOSAL ERYTHEMA 2
447 ORAL MUCOSAL EXFOLIATION 2
448 ORAL PAIN 2
449 OSMOTIC DEMYELINATION SYNDROME 2
450 OTOTOXICITY 2
451 PALPITATIONS 2
452 PARAESTHESIA ORAL 2
453 PERSONALITY CHANGE 2
454 PREMATURE BABY 2
455 PRODUCT ADHESION ISSUE 2
456 PRODUCT BLISTER PACKAGING ISSUE 2
457 PROTEIN TOTAL DECREASED 2
458 RENAL FAILURE ACUTE 2
459 RESPIRATORY DISORDER 2
460 SERUM FERRITIN DECREASED 2
461 SKIN IRRITATION 2
462 SNORING 2
463 SOMNAMBULISM 2
464 STEVENS-JOHNSON SYNDROME 2
465 STRESS 2
466 TACHYPHRENIA 2
467 TASTE DISORDER 2
468 THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION 2
469 THERAPEUTIC RESPONSE CHANGED 2
470 THIRST 2
471 TONGUE ERYTHEMA 2
472 TONGUE ULCERATION 2
473 TRANSFERRIN DECREASED 2
474 TRISMUS 2
475 TROPONIN INCREASED 2
476 ULCER 2
477 UNEVALUABLE EVENT 2
478 VERTIGO 2
479 WITHDRAWAL SYNDROME 2
480 WRONG PRODUCT ADMINISTERED 2
481 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2
482 ABDOMINAL PAIN LOWER 1
483 ABDOMINAL TENDERNESS 1
484 ABORTION SPONTANEOUS 1
485 ACCIDENTAL DEATH 1
486 ACCIDENTAL EXPOSURE TO PRODUCT 1
487 ACCIDENTAL POISONING 1
488 ACNE 1
489 ACUTE CORONARY SYNDROME 1
490 ACUTE MYOCARDIAL INFARCTION 1
491 ACUTE RESPIRATORY FAILURE 1
492 ADMINISTRATION SITE ERYTHEMA 1
493 ADMINISTRATION SITE REACTION 1
494 ADRENAL INSUFFICIENCY 1
495 ADRENAL MASS 1
496 ADRENOCORTICAL INSUFFICIENCY ACUTE 1
497 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 1
498 AGEUSIA 1
499 ALCOHOL USE 1
500 ALOPECIA AREATA 1
501 ANAPHYLACTIC REACTION 1
502 ANGULAR CHEILITIS 1
503 ANTICONVULSANT DRUG LEVEL DECREASED 1
504 ANXIETY DISORDER 1
505 APPLICATION SITE DERMATITIS 1
506 APPLICATION SITE DISCOMFORT 1
507 APPLICATION SITE DRYNESS 1
508 APPLICATION SITE EXFOLIATION 1
509 APPLICATION SITE INFLAMMATION 1
510 APPLICATION SITE LACERATION 1
511 APPLICATION SITE REACTION 1
512 APPLICATION SITE ULCER 1
513 ARTHROPATHY 1
514 ASCITES 1
515 ATAXIA 1
516 AUDITORY DISORDER 1
517 AUTISM SPECTRUM DISORDER 1
518 AUTOIMMUNE DISORDER 1
519 AUTONOMIC NEUROPATHY 1
520 BEHAVIOUR DISORDER 1
521 BINGE EATING 1
522 BLOOD ALBUMIN DECREASED 1
523 BLOOD ALKALINE PHOSPHATASE INCREASED 1
524 BLOOD BICARBONATE DECREASED 1
525 BLOOD CALCIUM DECREASED 1
526 BLOOD CHLORIDE DECREASED 1
527 BLOOD CHOLESTEROL DECREASED 1
528 BLOOD CHOLESTEROL INCREASED 1
529 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 1
530 BLOOD CREATININE DECREASED 1
531 BLOOD GLUCOSE DECREASED 1
532 BLOOD INSULIN INCREASED 1
533 BLOOD LACTATE DEHYDROGENASE INCREASED 1
534 BLOOD PHOSPHORUS DECREASED 1
535 BLOOD POTASSIUM DECREASED 1
536 BLOOD PRESSURE SYSTOLIC INCREASED 1
537 BLOOD UREA DECREASED 1
538 BLOOD UREA NITROGEN/CREATININE RATIO DECREASED 1
539 BODY MASS INDEX INCREASED 1
540 BODY TEMPERATURE INCREASED 1
541 BONE PAIN 1
542 BOWEL MOVEMENT IRREGULARITY 1
543 BRADYPHRENIA 1
544 BRAIN FOG 1
545 BREAST CANCER 1
546 BREAST NEOPLASM 1
547 BREAST PAIN 1
548 BRONCHITIS 1
549 CAMPTOCORMIA 1
550 CARBON DIOXIDE INCREASED 1
551 CARDIAC FAILURE 1
552 CARDIAC FAILURE CONGESTIVE 1
553 CATARRH 1
554 CENTRAL OBESITY 1
555 CEREBRAL DISORDER 1
556 CHANGE IN SEIZURE PRESENTATION 1
557 CHANGE OF BOWEL HABIT 1
558 CHOKING 1
559 CHOLECYSTITIS 1
560 CIRCADIAN RHYTHM SLEEP DISORDER 1
561 CIRCUMORAL OEDEMA 1
562 COLD SWEAT 1
563 COLITIS ISCHAEMIC 1
564 CONSCIOUSNESS FLUCTUATING 1
565 CONTRAINDICATED PRODUCT ADMINISTERED 1
566 CRYING 1
567 CULTURE STOOL POSITIVE 1
568 CUTANEOUS VASCULITIS 1
569 CYST 1
570 DECREASED ACTIVITY 1
571 DELUSION OF GRANDEUR 1
572 DELUSION OF REFERENCE 1
573 DELUSIONAL PERCEPTION 1
574 DEPENDENCE 1
575 DEPERSONALISATION/DEREALISATION DISORDER 1
576 DEPRESSIVE SYMPTOM 1
577 DEREALISATION 1
578 DERMATITIS ALLERGIC 1
579 DERMATITIS ATOPIC 1
580 DEVICE BREAKAGE 1
581 DEVICE USE ISSUE 1
582 DIASTOLIC DYSFUNCTION 1
583 DIFFUSE ALOPECIA 1
584 DIGEORGE^S SYNDROME 1
585 DILATATION VENTRICULAR 1
586 DIPLOPIA 1
587 DISCOMFORT 1
588 DISORGANISED SPEECH 1
589 DISTRACTIBILITY 1
590 DIVERTICULUM 1
591 DIZZINESS POSTURAL 1
592 DRUG DEPENDENCE 1
593 DRUG DETOXIFICATION 1
594 DRUG DIVERSION 1
595 DRUG EFFECT DECREASED 1
596 DRUG EFFECT VARIABLE 1
597 DRUG EXPOSURE DURING PREGNANCY 1
598 DRUG LEVEL ABOVE THERAPEUTIC 1
599 DRUG LEVEL BELOW THERAPEUTIC 1
600 DRUG TOLERANCE 1
601 DRY SKIN 1
602 EATING DISORDER 1
603 ECZEMA 1
604 EJACULATION DISORDER 1
605 EJECTION FRACTION DECREASED 1
606 ELECTROCARDIOGRAM QRS COMPLEX ABNORMAL 1
607 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1
608 ELECTROLYTE IMBALANCE 1
609 EMBOLISM 1
610 EMOTIONAL DISTRESS 1
611 ENCEPHALOPATHY 1
612 EOSINOPHIL COUNT DECREASED 1
613 EOSINOPHIL COUNT INCREASED 1
614 EPICONDYLITIS 1
615 EPILEPSY 1
616 EPISTAXIS 1
617 EXPIRED DRUG ADMINISTERED 1
618 EXPIRED PRODUCT ADMINISTERED 1
619 EXPOSURE TO TOXIC AGENT 1
620 EXTENSOR PLANTAR RESPONSE 1
621 EYE IRRITATION 1
622 EYE SYMPTOM 1
623 EYELID PTOSIS 1
624 FACE OEDEMA 1
625 FAECAL INCONTINENCE 1
626 FAECALOMA 1
627 FEELING GUILTY 1
628 FEELING HOT 1
629 FEELING OF DESPAIR 1
630 FEMUR FRACTURE 1
631 FLATULENCE 1
632 FLUID INTAKE REDUCED 1
633 FRUSTRATION TOLERANCE DECREASED 1
634 GASTRITIS 1
635 GASTROINTESTINAL DISORDER 1
636 GASTROINTESTINAL HAEMORRHAGE 1
637 GASTROINTESTINAL MOTILITY DISORDER 1
638 GASTROOESOPHAGEAL REFLUX DISEASE 1
639 GAZE PALSY 1
640 GENERALISED ANXIETY DISORDER 1
641 GENERALISED OEDEMA 1
642 GINGIVAL DISCOMFORT 1
643 GINGIVAL DISORDER 1
644 GLOBULINS DECREASED 1
645 GLOMERULAR FILTRATION RATE DECREASED 1
646 GLUCOSE URINE 1
647 GLUCOSE URINE PRESENT 1
648 GRANULOCYTOPENIA 1
649 HAEMATOCRIT DECREASED 1
650 HAEMATOMA 1
651 HAEMATURIA 1
652 HAEMODIALYSIS 1
653 HAEMOPTYSIS 1
654 HAIR COLOUR CHANGES 1
655 HAIR DISORDER 1
656 HAIR TEXTURE ABNORMAL 1
657 HEAD DISCOMFORT 1
658 HEAD INJURY 1
659 HEART RATE INCREASED 1
660 HEPATIC FAILURE 1
661 HEPATIC STEATOSIS 1
662 HEPATITIS 1
663 HICCUPS 1
664 HOMICIDE 1
665 HUNGER 1
666 HYPERAMMONAEMIA 1
667 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 1
668 HYPERLIPIDAEMIA 1
669 HYPEROSMOLAR STATE 1
670 HYPERREFLEXIA 1
671 HYPERSEXUALITY 1
672 HYPERTRICHOSIS 1
673 HYPOALBUMINAEMIA 1
674 HYPOCALCAEMIA 1
675 HYPOKALAEMIA 1
676 HYPOPHYSITIS 1
677 ILLNESS 1
678 ILLUSION 1
679 IMPAIRED GASTRIC EMPTYING 1
680 INCONTINENCE 1
681 INCORRECT ROUTE OF DRUG ADMINISTRATION 1
682 INFLAMMATION 1
683 INFLUENZA 1
684 INJECTION SITE ERYTHEMA 1
685 INJECTION SITE INDURATION 1
686 INJECTION SITE MASS 1
687 INJECTION SITE PAIN 1
688 INJECTION SITE REACTION 1
689 INJECTION SITE SWELLING 1
690 INTENTION TREMOR 1
691 INTENTIONAL DOSE OMISSION 1
692 INTENTIONAL PRODUCT USE ISSUE 1
693 INTERVERTEBRAL DISC PROTRUSION 1
694 INTRACRANIAL MASS 1
695 INTRADUCTAL PROLIFERATIVE BREAST LESION 1
696 IRRITABLE BOWEL SYNDROME 1
697 JOINT INJURY 1
698 JUDGEMENT IMPAIRED 1
699 LABILE BLOOD PRESSURE 1
700 LACERATION 1
701 LACK OF INJECTION SITE ROTATION 1
702 LEARNING DISABILITY 1
703 LEFT ATRIAL DILATATION 1
704 LEFT VENTRICULAR END-DIASTOLIC PRESSURE INCREASED 1
705 LIMB DISCOMFORT 1
706 LIMB INJURY 1
707 LIP OEDEMA 1
708 LIVER INJURY 1
709 LOSS OF LIBIDO 1
710 LYMPHADENOPATHY MEDIASTINAL 1
711 LYMPHOCYTE COUNT DECREASED 1
712 LYMPHOCYTE PERCENTAGE DECREASED 1
713 LYMPHOPENIA 1
714 MAGICAL THINKING 1
715 MALE SEXUAL DYSFUNCTION 1
716 MALNUTRITION 1
717 MASKED FACIES 1
718 MEAN CELL HAEMOGLOBIN DECREASED 1
719 MEAN CELL VOLUME DECREASED 1
720 MEDICATION RESIDUE 1
721 MENSTRUATION IRREGULAR 1
722 MENTAL FATIGUE 1
723 MESENTERIC LYMPHADENOPATHY 1
724 METABOLIC ALKALOSIS 1
725 METRORRHAGIA 1
726 MICTURITION URGENCY 1
727 MIOSIS 1
728 MONOCYTE COUNT DECREASED 1
729 MONOCYTE COUNT INCREASED 1
730 MORBID THOUGHTS 1
731 MOUTH SWELLING 1
732 MUCOCUTANEOUS ULCERATION 1
733 MUCOSAL DISORDER 1
734 MULTIPLE DRUG THERAPY 1
735 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1
736 MULTIPLE-DRUG RESISTANCE 1
737 MUSCULOSKELETAL DISCOMFORT 1
738 MYOCARDIAL DEPRESSION 1
739 MYOCARDITIS BACTERIAL 1
740 NASOPHARYNGITIS 1
741 NEAR DROWNING 1
742 NEPHROPATHY TOXIC 1
743 NEURODEGENERATIVE DISORDER 1
744 NEUROLOGICAL EXAMINATION ABNORMAL 1
745 NEUTROPHIL PERCENTAGE INCREASED 1
746 NEUTROPHILIA 1
747 NIGHT SWEATS 1
748 NOCTURIA 1
749 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 1
750 OBSESSIVE THOUGHTS 1
751 ODYNOPHAGIA 1
752 OESOPHAGITIS 1
753 OLIGOMENORRHOEA 1
754 OROPHARYNGEAL DISCOMFORT 1
755 OVARIAN CANCER 1
756 PAIN IN JAW 1
757 PANCREATIC NECROSIS 1
758 PANCREATITIS 1
759 PANIC ATTACK 1
760 PANIC DISORDER 1
761 PENIS DISORDER 1
762 PERIODONTAL DISEASE 1
763 PERIPHERAL COLDNESS 1
764 PERIPHERAL SWELLING 1
765 PERSONALITY CHANGE DUE TO A GENERAL MEDICAL CONDITION 1
766 PERSONALITY DISORDER 1
767 PHYSICAL ASSAULT 1
768 PICA 1
769 PLATELET COUNT DECREASED 1
770 PLATELET COUNT INCREASED 1
771 PLEURAL EFFUSION 1
772 PNEUMONIA ASPIRATION 1
773 PNEUMONITIS 1
774 PNEUMOTHORAX 1
775 POLYCYSTIC OVARIES 1
776 POLYURIA 1
777 POST-ACUTE COVID-19 SYNDROME 1
778 POSTURE ABNORMAL 1
779 PRESCRIBED OVERDOSE 1
780 PRESCRIBED UNDERDOSE 1
781 PRODUCT AFTER TASTE 1
782 PRODUCT DOSE OMISSION 1
783 PRODUCT NAME CONFUSION 1
784 PRODUCT PACKAGING DIFFICULT TO OPEN 1
785 PROTRUSION TONGUE 1
786 PSORIATIC ARTHROPATHY 1
787 PSYCHIATRIC SYMPTOM 1
788 PSYCHOLOGICAL TRAUMA 1
789 PULMONARY FIBROSIS 1
790 PULMONARY MASS 1
791 PYRAMIDAL TRACT SYNDROME 1
792 QUADRIPARESIS 1
793 QUALITY OF LIFE DECREASED 1
794 RALES 1
795 RECTAL HAEMORRHAGE 1
796 RED BLOOD CELL COUNT DECREASED 1
797 RED CELL DISTRIBUTION WIDTH INCREASED 1
798 RENAL CYST 1
799 REPETITIVE SPEECH 1
800 RESPIRATORY ACIDOSIS 1
801 RESPIRATORY DEPRESSION 1
802 RESPIRATORY TRACT INFECTION 1
803 RESTING TREMOR 1
804 RETCHING 1
805 RHEUMATOID ARTHRITIS 1
806 SARS-COV-2 TEST POSITIVE 1
807 SCHIZOAFFECTIVE DISORDER 1
808 SCREAMING 1
809 SEBORRHOEIC DERMATITIS 1
810 SECONDARY ADRENOCORTICAL INSUFFICIENCY 1
811 SELF-DESTRUCTIVE BEHAVIOUR 1
812 SENSORY LOSS 1
813 SEPSIS 1
814 SEPTIC SHOCK 1
815 SINUS BRADYCARDIA 1
816 SKIN DISORDER 1
817 SKIN INFECTION 1
818 SLEEP APNOEA SYNDROME 1
819 SLUGGISHNESS 1
820 SMALL INTESTINAL HAEMORRHAGE 1
821 SMALL INTESTINAL OBSTRUCTION 1
822 SPASMODIC DYSPHONIA 1
823 SPINAL COLUMN STENOSIS 1
824 SPINAL OSTEOARTHRITIS 1
825 SPLENIC CYST 1
826 STAUFFER^S SYNDROME 1
827 STRIDOR 1
828 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 1
829 SUDDEN CARDIAC DEATH 1
830 SUSPICIOUSNESS 1
831 SUTURE INSERTION 1
832 SWEAT GLAND DISORDER 1
833 SWELLING 1
834 SYMPTOM MASKED 1
835 SYRINGE ISSUE 1
836 SYSTEMIC LUPUS ERYTHEMATOSUS 1
837 SYSTOLIC DYSFUNCTION 1
838 TACHYARRHYTHMIA 1
839 TACHYPNOEA 1
840 THERAPEUTIC PRODUCT EFFECT VARIABLE 1
841 THERAPEUTIC RESPONSE DECREASED 1
842 THERAPY CHANGE 1
843 THERAPY INTERRUPTED 1
844 TIC 1
845 TONGUE DISORDER 1
846 TONGUE EXFOLIATION 1
847 TONGUE MOVEMENT DISTURBANCE 1
848 TONGUE SPASM 1
849 TORSADE DE POINTES 1
850 TRANSIENT ISCHAEMIC ATTACK 1
851 TRAUMATIC HAEMORRHAGE 1
852 TROPONIN T INCREASED 1
853 TYPE I HYPERSENSITIVITY 1
854 UPPER RESPIRATORY TRACT INFECTION 1
855 URETERIC OBSTRUCTION 1
856 URINARY HESITATION 1
857 URINARY INCONTINENCE 1
858 URINE ABNORMALITY 1
859 URTICARIA 1
860 VASODILATATION 1
861 VENTRICULAR ARRHYTHMIA 1
862 VENTRICULAR DYSSYNCHRONY 1
863 VENTRICULAR EXTRASYSTOLES 1
864 VENTRICULAR REMODELING 1
865 VIOLENCE-RELATED SYMPTOM 1
866 VISUAL ACUITY REDUCED 1
867 VITAMIN D DECREASED 1
868 VITAMIN D DEFICIENCY 1
869 WHEEZING 1
870 ZINC DEFICIENCY 1